Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.29 CNY -4.61% Market Closed
Market Cap: 8.1B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Jiangsu Kanion Pharmaceutical Co Ltd

Current Assets 3.9B
Cash & Short-Term Investments 2.3B
Receivables 1B
Other Current Assets 612.1m
Non-Current Assets 3.2B
Long-Term Investments 15.3m
PP&E 2.7B
Intangibles 413.4m
Other Non-Current Assets 60m
Current Liabilities 1.6B
Accounts Payable 230.9m
Accrued Liabilities 1.1B
Other Current Liabilities 277.8m
Non-Current Liabilities 345.4m
Other Non-Current Liabilities 345.4m

Balance Sheet
Jiangsu Kanion Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
554
222
248
295
378
408
769
937
1 601
1 969
Cash
0
0
0
0
0
0
0
937
1 601
1 969
Cash Equivalents
553
222
248
295
378
408
769
0
0
0
Short-Term Investments
0
9
0
0
0
1
5
176
170
460
Total Receivables
1 511
1 718
1 876
2 280
2 163
2 189
1 631
1 366
1 482
1 104
Accounts Receivables
942
956
976
1 107
1 196
1 058
955
732
728
654
Other Receivables
569
762
900
1 173
967
1 132
675
634
754
450
Inventory
145
188
192
204
249
275
377
338
343
350
Other Current Assets
46
29
27
16
51
32
105
57
134
166
Total Current Assets
2 255
2 166
2 344
2 795
2 841
2 905
2 886
2 874
3 730
4 050
PP&E Net
1 522
1 748
1 903
1 948
2 194
2 452
2 577
2 554
2 529
2 564
PP&E Gross
1 522
1 748
1 903
1 948
2 194
2 452
2 577
2 554
2 529
2 564
Accumulated Depreciation
395
472
557
672
788
888
1 005
1 139
1 284
1 369
Intangible Assets
232
314
384
418
474
443
482
434
398
369
Goodwill
59
59
59
59
59
59
59
59
59
59
Long-Term Investments
4
4
25
152
176
177
74
61
46
15
Other Long-Term Assets
83
15
16
22
77
75
42
37
34
61
Other Assets
59
59
59
59
59
59
59
59
59
59
Total Assets
4 155
N/A
4 305
+4%
4 730
+10%
5 394
+14%
5 821
+8%
6 111
+5%
6 119
+0%
6 018
-2%
6 796
+13%
7 117
+5%
Liabilities
Accounts Payable
205
254
256
237
235
222
242
321
362
228
Accrued Liabilities
45
57
63
106
74
751
529
534
843
1 030
Short-Term Debt
753
430
530
680
635
686
527
274
12
0
Current Portion of Long-Term Debt
56
80
45
0
30
0
0
0
0
0
Other Current Liabilities
367
464
546
678
734
270
399
324
565
350
Total Current Liabilities
1 425
1 285
1 439
1 702
1 708
1 928
1 696
1 453
1 781
1 609
Long-Term Debt
125
45
0
0
0
0
0
0
0
0
Minority Interest
57
60
63
108
124
151
160
168
180
188
Other Liabilities
49
104
85
99
99
95
96
92
81
128
Total Liabilities
1 656
N/A
1 494
-10%
1 587
+6%
1 908
+20%
1 931
+1%
2 175
+13%
1 952
-10%
1 714
-12%
2 042
+19%
1 925
-6%
Equity
Common Stock
514
514
616
616
616
593
593
593
585
585
Retained Earnings
1 466
1 777
2 007
2 343
2 709
3 169
3 399
3 720
4 136
4 544
Additional Paid In Capital
520
520
520
526
679
175
175
172
98
112
Treasury Stock
0
0
0
0
115
0
0
180
65
48
Other Equity
1
0
0
0
0
0
0
0
0
0
Total Equity
2 499
N/A
2 811
+12%
3 143
+12%
3 486
+11%
3 889
+12%
3 936
+1%
4 167
+6%
4 304
+3%
4 754
+10%
5 193
+9%
Total Liabilities & Equity
4 155
N/A
4 305
+4%
4 730
+10%
5 394
+14%
5 821
+8%
6 111
+5%
6 119
+0%
6 018
-2%
6 796
+13%
7 117
+5%
Shares Outstanding
Common Shares Outstanding
617
617
616
616
616
593
593
576
576
578

See Also

Discover More